As muscle biopsies do not represent a pure myogenic population of cells, we next investigated our PAX7 or DUX4 target gene biomarkers in FSHD patient-derived myoblast cell lines. The gene discussed is PAX7; the disease is facioscapulohumeral muscular dystrophy.